Seeking Alpha

OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, ...
KTLA

New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes

LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ELIAS ...
ucdavis.edu

New Bone Research Gives Hope to Kids and Dogs With Osteosarcoma

Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
Nasdaq

OS Therapies Announces Positive Data From The Study Of OST-HER2 In Osteosarcoma In Dogs

(RTTNews) - OS Therapies Inc. (OSTX) Thursday announced positive data for OST-HER2 in combination with palliative radiation in dogs with unresected appendicular osteosarcoma. Results from the study ...
The News-Gazette

Pet Talk | More than a limp: Understanding osteosarcoma in dogs

Two canine osteosarcoma patients who underwent amputations are shown in 2023, when their care team and owners celebrated their final chemo treatments by ringing a bell and giving both dogs lots of ...